Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prunella Vulgaris Tablets for Thyroid Nodules
ChiCTR2500096295Phase 4Completed
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Jan 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prunella vulgaris extract in thyroid nodule (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoint: Change in thyroid nodule size. Started Jan 2025; status: completed.
02
Drugs
prunella vulgaris extract
03
Conditions
thyroid nodule
Beyond the preview
Go deeper on ChiCTR2500096295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096295.